» Articles » PMID: 27335112

The Migraine Postdrome: An Electronic Diary Study

Overview
Journal Neurology
Specialty Neurology
Date 2016 Jun 24
PMID 27335112
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To report migraine postdrome symptoms in patients who report nonheadache symptoms as part of their attacks.

Methods: A prospective daily electronic diary study was conducted over 3 months in 120 patients with migraine. Nonheadache symptoms before, during, and after headache were collected on a daily basis. Visual analogue scales were used to capture the overall level of functioning and the severity of the headache. The postdrome was defined as the time from resolution of troublesome headache to return to normal.

Results: Of 120 evaluable patients, 97 (81%) reported at least one nonheadache symptom in the postdrome. Postdrome symptoms, in order of frequency, included feeling tired/weary and having difficulty concentrating and stiff neck. Many patients also reported a mild residual head discomfort. In most attacks (93%), there was return to normal within 24 hours after spontaneous pain resolved. There was no relationship between medication taken for the headache and the duration of the postdrome. The severity of the migraine was not associated with the duration of the postdrome. Overall state of health scores remained low during the postdrome.

Conclusion: Nonheadache symptoms in the postdrome were common and may contribute to the distress and disability in the patients studied. Postdrome symptoms merit larger observational studies and careful recording in clinical trials of acute and preventive migraine treatments.

Citing Articles

Brain connectivity in individuals with migraine resets during the headache phase: a whole-brain connectivity study.

Schulz E, Mayr A, Jahn P, Stankewitz A Brain Commun. 2025; 7(1):fcaf045.

PMID: 39958260 PMC: 11829205. DOI: 10.1093/braincomms/fcaf045.


Calcitonin-Gene-Related Peptide in Migraine and Tension-Type Headache in Children During Interictal Period.

Sekelj Fures J, Duranovic V, Lenicek Krleza J, Bojanac A, Loncar L, Dakovic I Diagnostics (Basel). 2024; 14(23).

PMID: 39682553 PMC: 11640429. DOI: 10.3390/diagnostics14232645.


Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.

Lipton R, Harriott A, Ma J, Smith J, Stokes J, Gandhi P Neurology. 2024; 103(6):e209745.

PMID: 39197113 PMC: 11379431. DOI: 10.1212/WNL.0000000000209745.


Postdromal symptoms in migraine: a REFORM study.

Thuraiaiyah J, Ashina H, Christensen R, Al-Khazali H, Ashina M J Headache Pain. 2024; 25(1):25.

PMID: 38383318 PMC: 10880332. DOI: 10.1186/s10194-024-01716-3.


Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.

Lipton R, Lanteri-Minet M, Leroux E, Manack Adams A, Contreras-De Lama J, Reed M J Headache Pain. 2023; 24(1):151.

PMID: 37940856 PMC: 10634176. DOI: 10.1186/s10194-023-01683-1.


References
1.
Maniyar F, Sprenger T, Monteith T, Schankin C, Goadsby P . Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2013; 137(Pt 1):232-41. DOI: 10.1093/brain/awt320. View

2.
Giffin N, Ruggiero L, Lipton R, Silberstein S, Tvedskov J, Olesen J . Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003; 60(6):935-40. DOI: 10.1212/01.wnl.0000052998.58526.a9. View

3.
Kelman L . The postdrome of the acute migraine attack. Cephalalgia. 2006; 26(2):214-20. DOI: 10.1111/j.1468-2982.2005.01026.x. View

4.
Blau J . Resolution of migraine attacks: sleep and the recovery phase. J Neurol Neurosurg Psychiatry. 1982; 45(3):223-6. PMC: 491341. DOI: 10.1136/jnnp.45.3.223. View

5.
Quintela E, Castillo J, Munoz P, Pascual J . Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia. 2006; 26(9):1051-60. DOI: 10.1111/j.1468-2982.2006.01157.x. View